KEMPHARM, INC Contracts & Agreements

131 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated July 15, 2019
Facility Agreements
KEMPHARM, INC
Pharmaceuticals
2019
Underwriting Agreement, dated as of August 8, 2024, by and between Zevra Therapeutics, Inc. and Cantor Fitzgerald & Co. and William Blair & Company, L.L.C
Underwriting Agreements
KEMPHARM, INC
2024
Equity Distribution Agreement, dated as of July 12, 2024, by and between Zevra Therapeutics, Inc. and Citizens JMP Securities, LLC
Equity Distribution Agreements
KEMPHARM, INC
2024
CREDIT AGREEMENT Dated as of April 5, 2024 among ZEVRA THERAPEUTICS, INC., as the Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER, as Guarantors, ALTER DOMUS (US) LLC, as the...
Credit Agreements
KEMPHARM, INC
2024
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
KEMPHARM, INC
2024
2023 Employment Inducement Award Plan and forms of award agreements thereunder
Employment Agreements
KEMPHARM, INC
2024
First Amendment to the Bridge Loan Agreement by and between the Registrant and Acer Therapeutics Inc
Loan Agreements
KEMPHARM, INC
2024
Form of Warrant
Warrant Agreements
KEMPHARM, INC
2023
Contingent Value Rights Agreement, dated as of November 17, 2023, by and among Zevra Therapeutics, Inc., Computershare, Inc., and Computershare Trust Company, N.A
KEMPHARM, INC
2023
Employment Agreement, effective as of October 10, 2023,between Zevra Therapeutics, Inc. and Neil F. McFarlane
Employment Agreements
KEMPHARM, INC
2023
Agreement and Plan of Merger dated as of August 30, 2023 by and among Zevra Therapeutics, Inc., Aspen Z Merger Sub, Inc., and Acer Therapeutics Inc
Merger Agreements
KEMPHARM, INC
2023
Bridge Loan Agreement dated as of August 30, 2023 by and between Zevra Therapeutics, Inc. and Acer Therapeutics Inc
Loan Agreements
KEMPHARM, INC
2023
Loan Purchase Agreement dated as of August 30, 2023 by and among Zevra Therapeutics, Inc., and Nantahala Capital Management, LLC and the other sellers party thereto
Loan Agreements
KEMPHARM, INC
2023
Note Purchase Agreement dated as of August 30, 2023 by and among Zevra Therapeutics, Inc., and Nantahala Capital Management, LLC and the other sellers party thereto
Note Agreements
KEMPHARM, INC
2023
Registration Rights Agreement dated as of August 30, 2023 by and among Zevra Therapeutics, Inc., and each of the sellers party thereto
Registration Rights Agreements
KEMPHARM, INC
2023
Voting and Support Agreement dated as of August 30, 2023 by and among Zevra Therapeutics, Inc., Aspen Z Merger Sub, Inc., and certain stockholders of Acer Therapeutics Inc
Merger Agreements
KEMPHARM, INC
2023
Ninth Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
KEMPHARM, INC
2023
Agreement Regarding Employment Terms, dated as of May 13, 2023, between Zevra Therapeutics, Inc. and Christal M.M. Mickle
Employment Agreements
KEMPHARM, INC
2023
Transition Agreement, dated as of May 6, 2023, between Zevra Therapeutics, Inc. and Richard W. Pascoe
Transition Agreements
KEMPHARM, INC
2023
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
KEMPHARM, INC
2023
EighthAmended and Restated Non-Employee Director Compensation Policyeffective February 15, 2023
Compensation Agreements
KEMPHARM, INC
2023
2023 Employment Inducement Award Plan and forms of award agreements thereunder
Employment Agreements
KEMPHARM, INC
2023
Amendment to Employment Agreement, dated as of January 6, 2023, between KemPharm, Inc. and Richard W. Pascoe
Employment Agreements
KEMPHARM, INC
Pharmaceuticals
2023
Transition Agreement, dated as of January 4, 2023, as amended, between KemPharm, Inc. and Travis C. Mickle, Ph.D
Transition Agreements
KEMPHARM, INC
Pharmaceuticals
2023
Consulting Agreement, dated as of January 6, 2023, between KemPharm, Inc. and Travis C. Mickle, Ph.D
Consulting Agreements
KEMPHARM, INC
Pharmaceuticals
FL
2023
Revolving Loan Agreement dated May 31, 2022 by and among KemPharm, Inc. and Ameris Bank, as lender
Loan Agreements
KEMPHARM, INC
Pharmaceuticals
FL
2022
Asset Purchase Agreement by and among KemPharm, Inc., KemPharm Denmark A/S and Orphazyme A/S in restructuring, dated May 15, 2022
Purchase Agreements
KEMPHARM, INC
2022
Seventh Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
KEMPHARM, INC
Pharmaceuticals
2022
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
KEMPHARM, INC
Pharmaceuticals
2022
Executive Employment Agreement by and between the Registrant and Richard W. Pascoe, dated as of November 5, 2021
Employment Agreements
KEMPHARM, INC
2021
Amendment No. 1 to Collaboration and License Agreement, effective as of April 8, 2021, by and between the Company and Commave Therapeutics SA
Collaboration Agreements
KEMPHARM, INC
Pharmaceuticals
2021
Amended and Restated 2014 Equity Incentive Plan
Bonus & Incentive Agreements
KEMPHARM, INC
Pharmaceuticals
DE
2021
2021 Employee Stock Purchase Plan
Stock Agreements
KEMPHARM, INC
2021
Equity Distribution Agreement, dated July 2, 2021, by and among KemPharm, Inc., JMP Securities LLC and RBC Capital Markets, LLC
Equity Distribution Agreements
KEMPHARM, INC
2021
Form of Inducement Warrant
Warrant Agreements
KEMPHARM, INC
2021
Form of Inducement Letter
KEMPHARM, INC
Pharmaceuticals
2021
Specimen stock certificate evidencing shares of Common Stock
Stock Agreements
KEMPHARM, INC
Pharmaceuticals
2021
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
KEMPHARM, INC
2021
Sixth Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
KEMPHARM, INC
Pharmaceuticals
2021
Payoff letter, dated as of February 8, 2021, by and among the Company and the lenders named therein
KEMPHARM, INC
2021
Form of Inducement Warrant
Warrant Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2021
Form of Inducement Letter
KEMPHARM, INC
2021
Form of Common Stock Purchase Warrant and schedule of holders
Warrant Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2021
Series A Common Stock Purchase Warrant for Underwriter
Warrant Agreements
KEMPHARM, INC
2021
Amendment to Senior Secured Convertible Notes and Amendment to Warrant, dated as of January 12, 2021, by and among the Company, Deerfield Private Design Fund III, L.P. and...
Warrant Agreements
KEMPHARM, INC
2021
Form of Underwriting Agreement
Underwriting Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2021
Amendment to Facility Agreement, Notes and to December 2020 Exchange Agreement, dated as of December 24, 2020, by and among KemPharm, Inc., Deerfield Private Design Fund III, L.P....
Exchange Agreements
KEMPHARM, INC
2020
Joinder Agreement, dated as of December 23, 2020, by and between KemPharm, Inc. and Delaware Street Capital Master Fund, L.P
Joinder Agreements
KEMPHARM, INC
2020
Joinder Agreement, dated as of December 23, 2020, by and between KemPharm, Inc. and M. Kingdon Offshore Master Fund, LP
Joinder Agreements
KEMPHARM, INC
Pharmaceuticals
2020
December 2020 Exchange Agreement and Amendment to Facility Agreement, Notes and Investors Rights Agreement, dated as of December 20, 2020, by and among KemPharm, Inc., Deerfield...
Exchange Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2020
Form of Underwriting Agreement
Underwriting Agreements
KEMPHARM, INC
2020
Form of Common Stock Warrant
Warrant Agreements
KEMPHARM, INC
2020
Form of Pre-Funded Warrant
Warrant Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2020
Termination of Agreement of Sublease, by and between KemPharm, Inc. and Ciber Global, LLC, dated as of October 22, 2020
Lease Agreements
KEMPHARM, INC
Pharmaceuticals
2020
Amended and Restated Bylaws of KemPharm, Inc., effective as of July 15, 2020
KEMPHARM, INC
Pharmaceuticals
DE
2020
Fifth Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
KEMPHARM, INC
2020
Registration Rights Agreement dated February 28, 2019 by and between the Company and Lincoln Park Capital Fund, LLC (incorporated herein by reference to the Registrant's Annual...
Registration Rights Agreements
KEMPHARM, INC
2020
Agreement to Sublease, by and between KemPharm, Inc. and Ciber Global, LLC, dated as of January 15, 2020
Lease Agreements
KEMPHARM, INC
Pharmaceuticals
2020
Purchase Agreement, dated as of February 17, 2020, by and between KemPharm, Inc. and Lincoln Park Capital Fund, LLC
Purchase Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2020
Registration Rights Agreement, dated as of February 17, 2020, by and between KemPharm, Inc. and Lincoln Park Capital Fund, LLC
Registration Rights Agreements
KEMPHARM, INC
2020
Amendment to Senior Secured Convertible Notes and Amendment to Warrant, dated as of February 17, 2020, by and among KemPharm, Inc. and the noteholders party thereto
Warrant Agreements
KEMPHARM, INC
2020
January 2020 Exchange Agreement, dated as of January 12, 2020, by and between KemPharm, Inc. and M. Kingdon Offshore Master Fund, LP
Exchange Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2020
Senior Secured Convertible Note, dated as of January 13, 2020
Note Agreements
KEMPHARM, INC
2020
Amendment to December 2019 Notes and Consent, dated as of January 12, 2020, by and among KemPharm, Inc. and the signatories party thereto
Note Agreements
KEMPHARM, INC
2020
December 2019 Exchange Agreement and Amendment to Facility Agreement, Senior Secured Convertible Notes and Warrants, dated as of December 17, 2019, by and among KemPharm, Inc.,...
Exchange Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2019
Amendment to September 2019 Exchange Agreement and Amendment to Facility Agreement, dated as of December 17, 2019, by and among KemPharm, Inc., Deerfield Private Design Fund III,...
Exchange Agreements
KEMPHARM, INC
Pharmaceuticals
2019
Form of Senior Secured Convertible Note, with a schedule of noteholders
Note Agreements
KEMPHARM, INC
2019
Amended and Restated Senior Secured Convertible Note issued to Deerfield Private Design Fund III, L.P., dated as of December 18, 2019
Note Agreements
KEMPHARM, INC
2019
Amended and Restated Guaranty and Security Agreement, dated as of December 18, 2019, by and among KemPharm, Inc., each other Grantor party thereto, each Guarantor party thereto...
Guaranty Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2019
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated August 16, 2019
Facility Agreements
KEMPHARM, INC
Pharmaceuticals
2019
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated August 23, 2019
Facility Agreements
KEMPHARM, INC
2019
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated August 30, 2019
Facility Agreements
KEMPHARM, INC
Pharmaceuticals
2019
Fourth Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
KEMPHARM, INC
2019
Agreement to Terminate CLA, by and between MonoSol Rx, LLC and the Registrant, dated as of March 20, 2012
KEMPHARM, INC
2019
September 2019 Exchange Agreement and Amendment to Facility Agreement, dated as of September 3, 2019, by and among KemPharm, Inc., Deerfield Private Design Fund III, L.P. and...
Exchange Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2019
Collaboration and License Agreement, dated as of September 3, 2019, by and between KemPharm, Inc. and Boston Pharmaceuticals Holdings SA
Collaboration Agreements
KEMPHARM, INC
2019
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated June 3, 2019
Facility Agreements
KEMPHARM, INC
Pharmaceuticals
2019
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated June 17, 2019
Facility Agreements
KEMPHARM, INC
Pharmaceuticals
2019
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated June 24, 2019
Facility Agreements
KEMPHARM, INC
2019
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated June 28, 2019
Facility Agreements
KEMPHARM, INC
Pharmaceuticals
2019
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated July 31, 2019
Facility Agreements
KEMPHARM, INC
2019
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated August 9, 2019
Facility Agreements
KEMPHARM, INC
2019
Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under 2014 Equity Incentive Plan
Bonus & Incentive Agreements
KEMPHARM, INC
2019
Registration Rights Agreement dated February 28, 2019 by and between the Company and Lincoln Park Capital Fund, LLC
Registration Rights Agreements
KEMPHARM, INC
2019
Seventh Amendment to Senior Secured Convertible Note and Sixth Amendment to Warrant, dated February 28, 2019, between the Company and Deerfield Private Design Fund III, L.P
Warrant Agreements
KEMPHARM, INC
2019
Amended Non-Employee Director Compensation Policy
Compensation Agreements
KEMPHARM, INC
2019
Warrant to Purchase Shares of Common Stock issued to KVK Tech, Inc. dated October 25, 2018
Warrant Agreements
KEMPHARM, INC
2019
Purchase Agreement dated February 28, 2019 by and between the Company and Lincoln Park Capital Fund, LLC
Purchase Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2019
Collaboration and License Agreement by and between the Company and KVK Tech, Inc. dated as of October 25, 2018
Collaboration Agreements
KEMPHARM, INC
Pharmaceuticals
DE
2019
Supplemental Indenture, dated November 20, 2018, between KemPharm, Inc. and U.S. Bank National Association, as trustee
Indenture Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2018
Amendment to Convertible Note and Warrant, dated November 20, 2018, between KemPharm, Inc. and Deerfield Private Design Fund III, L.P
Warrant Agreements
KEMPHARM, INC
2018
Separation Agreement and General Release by and between the Registrant and Daniel L. Cohen, dated as of September 5, 2018
Separation Agreements
KEMPHARM, INC
Pharmaceuticals
2018
Underwriting Agreement by and among KemPharm, Inc. and RBC Capital Markets, LLC, dated October 5, 2018
Underwriting Agreements
KEMPHARM, INC
2018
Exchange Agreement, dated as of October 5, 2018, by and among KemPharm, Inc., Deerfield Private Design Fund III, L.P. and Deerfield Special Situations Fund, L.P
Exchange Agreements
KEMPHARM, INC
2018
Common Stock Sales Agreement, dated September 4, 2018, by and between KemPharm, Inc. and RBC Capital Markets, LLC
Stock Agreements
KEMPHARM, INC
Pharmaceuticals
DE
2018
Facility Agreement Waiver and Fifth Amendment to Senior Secured Convertible Note by and between the Company and Deerfield Private Design Fund III, L.P., dated as of June 11, 2018
Note Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2018
KemPharm, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
KEMPHARM, INC
Pharmaceuticals
2018
Lease Agreement, by and between KemPharm, Inc. and the Board of Regents, State of Iowa for the Use and Benefit of the University of Iowa, dated as of September 5, 2017
Lease Agreements
KEMPHARM, INC
2018
Office Lease CELEBRATION OFFICE CENTER II 1170 CELEBRATION BOULEVARD CELEBRATION, FLORIDA Between BRE/COH FL LLC, a Delaware limited liability company as Landlord, and KEMPHARM,...
Limited Liability Company Agreements
KEMPHARM, INC
2017
FIRST AMENDMENT
KEMPHARM, INC
2017
SECOND AMENDMENT
KEMPHARM, INC
Pharmaceuticals
2017
THIRD AMENDMENT
KEMPHARM, INC
Pharmaceuticals
2017
LEASE DOCUMENT FOR THE UNIVERSITY OF IOWA BIOVENTURES CENTER
Lease Agreements
KEMPHARM, INC
2016
KEMPHARM, INC. COMMON STOCK SALES AGREEMENT
Stock Agreements
KEMPHARM, INC
2016
FOURTH AMENDMENT TO SENIOR SECURED CONVERTIBLE NOTE AND WARRANT
Warrant Agreements
KEMPHARM, INC
2016
KemPharm, Inc. Employment Agreement Daniel L. Cohen Effective as of April 13, 2016 KemPharm, Inc. Employment Agreement
Employment Agreements
KEMPHARM, INC
2016
KemPharm, Inc. Amended and Restated Employment Agreement Sven Guenther Effective as of April 13, 2016 KemPharm, Inc. Amended and Restated Employment Agreement
Employment Agreements
KEMPHARM, INC
2016
KemPharm, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
KEMPHARM, INC
2016
SECOND AMENDMENT TO SENIOR SECURED CONVERTIBLE NOTE AND WARRANT
Warrant Agreements
KEMPHARM, INC
2016
SECOND AMENDMENT TO FACILITY AGREEMENT
Facility Agreements
KEMPHARM, INC
2015
SECONDAMENDMENT TO FACILITY AGREEMENT
Facility Agreements
KEMPHARM, INC
2015
Amendment to Employment Agreement
Employment Agreements
KEMPHARM, INC
2015
Amendment to Amended and Restated Employment Agreement
Employment Agreements
KEMPHARM, INC
2015
Amendment to Amended and Restated Employment Agreement
Employment Agreements
KEMPHARM, INC
2015
Amendment to Employment Agreement
Employment Agreements
KEMPHARM, INC
Pharmaceuticals
2015
Amendment to Employment Agreement
Employment Agreements
KEMPHARM, INC
2015
KemPharm, Inc. Employment Agreement
Employment Agreements
KEMPHARM, INC
2015
KemPharm, Inc. Amended and Restated Employment Agreement
Employment Agreements
KEMPHARM, INC
Pharmaceuticals
IA
2015
KemPharm, Inc. Amended and Restated Employment Agreement
Employment Agreements
KEMPHARM, INC
Pharmaceuticals
IA
2015
KemPharm, Inc. Employment Agreement Tracy Woody Dated March 30, 2015 KemPharm, Inc. Employment Agreement
Employment Agreements
KEMPHARM, INC
2015
AGREEMENT TO TERMINATE CLA BETWEEN MONOSOL RX, LLC AND KEMPHARM, INC. DATED AS OF MARCH 20, 2012 Agreement to Terminate CLA Between MONOSOL, RX and KemPharm,
Term Sheets
KEMPHARM, INC
Pharmaceuticals
2015
[Number of Shares] KEMPHARM, INC. CommonStock UNDERWRITING AGREEMENT
Underwriting Agreements
KEMPHARM, INC
2015
ASSET PURCHASE AGREEMENT between SHIRE LLC and TRAVIS C.MICKLE, PH.D., AND KEMPHARM, INC. dated as of March 21, 2012
Purchase Agreements
KEMPHARM, INC
2015
MATERIAL SUPPLY AGREEMENT
Supply Agreements
KEMPHARM, INC
Pharmaceuticals
IA
2015
AGREEMENT TO TERMINATE CLA BETWEEN MONOSOL RX, LLC AND KEMPHARM, INC. DATED AS OF MARCH 20, 2012 Agreement to Terminate CLA Between MONOSOL, RX and KemPharm,
Term Sheets
KEMPHARM, INC
Pharmaceuticals
2015
KEMPHARM, INC. INCENTIVE STOCK PLAN
Bonus & Incentive Agreements
KEMPHARM, INC
2015
KEMPHARM, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:NOVEMBER 7, 2014 APPROVED BY THE STOCKHOLDERS:APRIL 1, 2015 IPO DATE/EFFECTIVE DATE: , 2015
Bonus & Incentive Agreements
KEMPHARM, INC
Pharmaceuticals
DE
2015
ASSET PURCHASE AGREEMENT between SHIRE LLC and TRAVIS C.MICKLE, PH.D., AND KEMPHARM, INC. dated as of March 21, 2012
Purchase Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2015
MATERIAL SUPPLY AGREEMENT
Supply Agreements
KEMPHARM, INC
2015
FACILITY AGREEMENT
Facility Agreements
KEMPHARM, INC
2015
FIRST AMENDMENT TO FACILITY AGREEMENT, SENIOR SECURED CONVERTIBLE NOTE AND WARRANT
Warrant Agreements
KEMPHARM, INC
Pharmaceuticals
NY
2015